The ExoVasc® Personalised External Aortic Root Support is a revolutionary new device. It is designed to manage aortic dilation in people with Marfan syndrome and related genetic conditions. 

The ExoVasc® is placed around the ascending aorta where it provides support to the patient’s own aorta and aortic valve and is designed to prevent enlargement and rupture.

A further application is in the Ross Operation where the ExoVasc® is used to manage dilation of the transplanted pulmonary valve when replacing the first part of the aorta.

This innovation developed by Exstent Limited sets a new standard in the surgical management of the dilated aorta. More than 800 patients have now received their ExoVasc® support and its effectiveness is proven by a total of over 2,000 patient-years’ experience gained during the past 19 years.

Biotechnology

Health Care

Health Diagnostics

Medical Devices

Technology

EXSTENT LIMITED

EXSTENT LIMITED's headquarters in Tewkesbury, United Kingdom

EXSTENT LIMITED

Org chart

Teams

Offices

Similar companies